The route being marketed has run ahead of the evidence
We examine its mechanisms, complementary therapies, and the importance of individualized, well-rounded treatment
Additionally, AOD 9604 is not on the FDA-approved bulk substance list, and thus is not eligible to be compounded
This does not affect your statutory rights.
Product Purity & Contamination Concerns The major BPC-157 contamination risk comes from purchasing tainted or mislabeled vials from the research use only market, especially when no valid COA is provided
Product labels may contain important safety information and the most recent product information provided by the product manufacturers should be carefully reviewed prior to use to verify the dose, administration, and contraindications